World Journal of Endocrine Surgery

Register      Login

VOLUME 10 , ISSUE 2 ( May-August, 2018 ) > List of Articles


Association between Nonspecific Chronic Lymphocytic Thyroiditis and Differentiated Epithelial Thyroid Carcinoma: Clinicopathological Analysis of Patients Who underwent Thyroidectomy in a Tertiary Care Center in Sri Lanka

Suwin N Hewage, Palitha Ratnayake, Nadeesha Jeewan Nawarathna, Ranjith JK Senevirathne, Sonali SC Gunatilake, Nimeda L Kariyawasam, Rasika Shyamalie, Priyanga Yogachandran

Keywords : Age, Differentiated thyroid carcinoma, Gender, Nonspecific chronic lymphocytic thyroiditis.

Citation Information : Hewage SN, Ratnayake P, Nawarathna NJ, Senevirathne RJ, Gunatilake SS, Kariyawasam NL, Shyamalie R, Yogachandran P. Association between Nonspecific Chronic Lymphocytic Thyroiditis and Differentiated Epithelial Thyroid Carcinoma: Clinicopathological Analysis of Patients Who underwent Thyroidectomy in a Tertiary Care Center in Sri Lanka. World J Endoc Surg 2018; 10 (2):119-126.

DOI: 10.5005/jp-journals-10002-1230

License: CC BY-NC 4.0

Published Online: 01-10-2007

Copyright Statement:  Copyright © 2018; The Author(s).


Introduction: The most common differentiated malignant thyroid neoplasm is papillary carcinoma. The association of concurrent presence of chronic lymphocytic thyroiditis and its subtypes with differentiated epithelial thyroid carcinoma remains controversial. Objective: To evaluate the epidemiological factors of chronic lymphocytic thyroiditis and association between chronic lymphocytic thyroiditis and its subtypes with differentiated epithelial thyroid carcinoma. Materials and methods: The histopathological records of 684 patients who underwent thyroidectomy at Teaching Hospital Kandy, Sri Lanka, for a period of 2½ years from January 2013 were reviewed. Their clinical and pathological characteristics were analyzed. Chronic lymphocytic thyroiditis was diagnosed by histology. Results: Thyroid malignancies were detected in 14.2% of thyroidectomy specimen, of which well-differentiated epithelial thyroid carcinoma was seen in 82%. Chronic lymphocytic thyroiditis was present in 31%, out of which 73.1% were nonspecific chronic lymphocytic thyroiditis and 26.9% were Hashimoto's thyroiditis. Gender, age, and presence of thyroiditis were significantly associated with papillary thyroid carcinoma. In the analyzed sample, males were more likely to have papillary carcinoma compared with females (p = 0.013). Those with nonspecific chronic lymphocytic thyroiditis were more likely to have papillary thyroid carcinoma (p = 0.002) compared with those without. With increasing age, the proportion of lymphovascular invasion in patients with papillary thyroid carcinoma significantly (p = 0.010) decreases. None of the three factors mentioned were significant predictors of presence of follicular carcinoma, tumor focality, capsular or lymphovascular invasion in papillary or follicular carcinoma. Conclusion: The presence of nonspecific chronicl ymphocytic thyroiditis is associated with papillary thyroid carcinoma at a given age and gender. Influence of nonspecific chronic lymphocytic thyroiditis on the prognosis of well-differentiated epithelial thyroid carcinoma needs to be investigated further with a larger sample size.

PDF Share
  1. Caturegli P, De Remigis A, Chuang K, Dembele M, Iwama A, Iwama S. Hashimoto's thyroiditis: celebrating the centennial through the lens of the Johns Hopkins hospital surgical pathology records. Thyroid 2013 Feb;23(2):142-150.
  2. Konturek A, BarczyNski M, Wierzchowski W, Stopa M, Nowak W. Coexistence of papillary thyroid cancer with Hashimoto thyroiditis. Langenbecks Arch Surg 2013 Mar; 398(3):389-394.
  3. Dailey ME, Lindsay S, Skahen R. Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. AMA Arch Surg 1955 Feb;70(2):291-297.
  4. Hirabayashi RN, Lindsay S. The relation of thyroid carcinoma and chronic thyroiditis. Surg Gynecol Obstet 1965 Aug;121:243-252.
  5. Singh B, Shaha AR, Trivedi H, Carew JF, Poluri A, Shah JP. Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome. Surgery 1999 Dec;126(6):1070-1076.
  6. Ott RA, McCall AR, McHenry C, Jarosz H, Armin A, Lawrence AM, Paloyan E. The incidence of thyroid carcinoma in Hashimoto's thyroiditis. Am Surg 1987 Aug;53(8):442-445.
  7. Okayasu I, Fujiwara M, Hara Y, Tanaka Y, Rose NR. Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans. Cancer 1995 Dec;76(11): 2312-2318.
  8. Repplinger D, Bargren A, Zhang YW, Adler JT, Haymart M, Chen H. Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer? J Surg Res 2008 Nov;150(1):49-52.
  9. Kim KW, Park YJ, Kim EH, Park SY, Park DJ, Ahn SH, Park do J, Jang HC, Cho BY. Elevated risk of papillary thyroid cancer in Korean patients with Hashimoto's thyroiditis. Head Neck 2011 May;33(5):691-695.
  10. Haymart MR, Repplinger DJ, Leverson GE, Elson DF, Sippel RS, Jaume JC, Chen H. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumour stage. J Clin Endocrinol Metab 2008 Mar;93(3):809-814.
  11. Holm LE, Blomgren H, Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 1985 Mar;312(10):601-604.
  12. Rago T, Di Coscio G, Ugolini C, Scutari M, Basolo F, Latofa F, Romani R, Berti P, Grasso L, Braverman LE, et al. Clinical features of thyroid autoimmunity are associated with thyroiditis on histology and are not predictive of malignancy in 570 patients with indeterminate nodules oncytology who had a thyroidectomy. Clin Endocrinol (Oxf) 2007 Sep;67(3): 363-369.
  13. Crile G Jr. Struma lymphomatosa and carcinoma of the thyroid. Surg Gynecol Obstet 1978 Sep;147(3):350-352.
  14. Anil C, Goksel S, Gursoy A. Hashimoto's thyroiditis is not associated with increased risk of thyroid cancer in patients with thyroid nodules: a single-center prospective study. Thyroid 2010 Jun;20(6):601-606.
  15. Gasbarri A, Sciacchitano S, Marasco A, Papotti M, Di Napoli A, Marzullo A, Yushkov P, Ruco L, Bartolazzi A. Detection and molecular characterization of thyroid cancer precursor lesions in a specific subset of Hashimoto's thyroiditis. Br J Cancer 2004 Sep;91(6):1096-1104.
  16. Prasad ML, Huang Y, Pellegata NS, de la Chapelle A, Kloos RT. Hashimoto's thyroiditis with papillary thyroid carcinoma (papillary thyroid carcinoma)-like nuclear alterations express molecular markers of papillary thyroid carcinoma. Histopathology 2004 Jul;45(1):39-46.
  17. Wijeyaratne CN, Jayasinghe A, de Silva DG, Parkes AB, Lazarus JH, Premawardhana LD. Iodine prophylaxis, goitre and thyroid autoimmunity in Sri Lanka. Ceylon Med J 2005 Mar;50(1):20-23.
  18. Kashima K, Yokoyama S, Noguchi S, Murakami N, Yamashita H, Watanabe S, Uchino S, Toda M, Sasaki A, Daa T, et al. Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma. Thyroid 1998 Mar;8(3):197-202.
  19. Loh KC, Greenspan FS, Dong F, Miller TR, Yeo PP. Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 1999 Feb;84(2):458-463.
  20. Schaff ler A, Palitzsch KD, Seiffarth C, Höhne HM, Riedhammer FJ, Hofstädter F, Schölmerich J, Rüschoff J. Coexistent thyroiditis is associated with lower tumour stage in thyroid carcinoma. Eur J Clin Invest 1998 Oct;28(10):838-844.
  21. Del Rio P, Cataldo S, Sommaruga L, Concione L, Arcuri MF, Sianesi M. The association between papillary carcinoma and chronic lymphocytic thyroiditis: does it modify the prognosis of cancer. Minerva Endocrinol 2008 Mar;33(1):1-5.
  22. Kebebew E, Treseler PA, Ituarte PH, Clark OH. Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited. World J Surg 2001 May;25(5):632-637.
  23. Kumarasinghe P. Morphologic assessment of thyroid disease by cytology and pattern of thyroid enlargement in Sri Lanka. J Ceylon Coll Physicians 1998;31(1-2):31-40.
  24. Fernando RF, Chandrasinghe PC, Pathmeswaran AA. The prevalence of autoimmune thyroiditis after universal salt iodisation in Srilanka. Ceylon Med J 2012 Sep;57(3):116-119.
  25. Ratnatunga PC, Amarasinghe SC, Ratnatunga NV. Changing patterns of thyroid cancer in Sri Lanka. Has the iodination program helped? Ceylon Med J 2003 Dec;48(4):125-128.
  26. Matesa-Aniæ D, Matesa N, Dabeliæ N, Kusiæ Z. Coexistence of papillary carcinoma and Hashimoto's thyroiditis. Acta Clin Croat 2009 Mar;48(1):9-12.
  27. Shih ML, Lee JA, Hsieh CB, Yu JC, Liu HD, Kebebew E, Clark OH, Duh QY. Thyroidectomy for Hashimoto's thyroiditis: complications and associated cancers. Thyroid 2008 Jul;18(7):729-734.
  28. Dikliæ A, Zivaljeviæ V, Paunoviæ I, Kaleziæ N, Tatiæ S. Surgical procedures in patients with thyroid autoimmune disease. Srp Arh Celok Lek 2005 Oct;133(Suppl 1):77-83.
  29. Strauss M, Laurian N, Antebi E. Coexistent carcinoma of the thyroid gland and Hashimoto's thyroiditis. Surg Gynecol Obstet 1983 Sep;157(3):228-232.
  30. Koo BS, Yoon YH, Kim JM, Choi EC, Lim YC. Predictive factors of level IIb lymph node metastasis in patients with papillary thyroid carcinoma. Ann Surg Oncol 2009 May; 16(5):1344-1347.
  31. Mercante G, Frasoldati A, Pedroni C, Formisano D, Renna L, Piana S, Gardini G, Valcavi R, Barbieri V. Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid 2009 Jul;19(7):707-716.
  32. Sciuto R, Romano L, Rea S, Marandino F, Sperduti I, Maini CL. Natural history and clinical outcome of differentiated thyroid carcinoma: a retrospective analysis of 1503 patients treated at a single institution. Ann Oncol 2009 Oct;20(10):1728-1735.
  33. Matsubayashi S, Kawai K, Matsumoto Y, Mukuta T, Morita T, Hirai K, Matsuzuka F, Kakudoh K, Kuma K, Tamai H. The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland. J Clin Endocrinol Metab 1995 Dec;80(12):3419-3424.
  34. Ozaki O, Ito K, Mimura T, Sugino K, Hosoda Y. Papillary carcinoma of the thyroid: tall-cell variant with extensive lymphocyte infiltration. Am J Surg Pathol 1996 Jun;20(6): 695-698.
  35. Pellegriti G, Belfiore A, Giuffrida D, Lupo L, Vigneri R. Outcome of differentiated thyroid cancer in Graves’ patients. J Clin Endocrinol Metab 1998 Aug;83(8):2805-2809.
  36. Ozaki O, Ito K, Kobayashi K, Toshima K, Iwasaki H, Yashiro T. Thyroid carcinoma in Graves’ disease. World J Surg 1990 May-Jun;14(3):437-440.
  37. Muzza M, Degl'Innocenti D, Colombo C, Perrino M, Ravasi E, Rossi S, Cirello V, Beck-Peccoz P, Borrello MG, Fugazzola L. The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies. Clin Endocrinol (Oxf) 2010 May;72(5):702-708.
  38. Huang BY, Hseuh C, Chao TC, Lin KJ, Lin JD. Well-differentiated thyroid carcinoma with concomitant Hashimoto's thyroiditis present with less aggressive clinical stage and low recurrence. Endocr Pathol 2011 Sep;22(3):144-149.
  39. David T, Hughes, Megan R, Haymart, Barbra S, Miller, Paul G, et al. The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years Thyroid 2011;21: 231-236.
  40. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 1998 Dec;83(12):2638-2648.
  41. Gilliland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma: a population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer 1997 Feb;79(3):564-573.
  42. Mazzaferri EL, Kloos RT. Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001 Apr;86(4):1447-1463.
  43. Dean DS, Hay ID. Prognostic indicators in differentiated thyroid carcinoma. Cancer Control 2000 May-Jun;7(3): 229-239.
  44. Greene, FL.; Page, DL.; Fleming, ID.; FritzAG.; Balch, CM.; Haller, DG.; Morrow, M.; editors. Thyroid. In: American Joint Committee on Cancer: cancer staging manual. 6th ed. New York: Springer-Verlag; 2002. pp. 77-87.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.